1. Home
  2. CDIO vs PZG Comparison

CDIO vs PZG Comparison

Compare CDIO & PZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • PZG
  • Stock Information
  • Founded
  • CDIO 2017
  • PZG 1992
  • Country
  • CDIO United States
  • PZG United States
  • Employees
  • CDIO N/A
  • PZG N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • PZG Metal Mining
  • Sector
  • CDIO Health Care
  • PZG Basic Materials
  • Exchange
  • CDIO Nasdaq
  • PZG Nasdaq
  • Market Cap
  • CDIO 19.5M
  • PZG 20.3M
  • IPO Year
  • CDIO N/A
  • PZG 1999
  • Fundamental
  • Price
  • CDIO $0.48
  • PZG $0.39
  • Analyst Decision
  • CDIO Buy
  • PZG
  • Analyst Count
  • CDIO 1
  • PZG 0
  • Target Price
  • CDIO $2.00
  • PZG N/A
  • AVG Volume (30 Days)
  • CDIO 763.1K
  • PZG 335.0K
  • Earning Date
  • CDIO 05-14-2025
  • PZG 05-13-2025
  • Dividend Yield
  • CDIO N/A
  • PZG N/A
  • EPS Growth
  • CDIO N/A
  • PZG N/A
  • EPS
  • CDIO N/A
  • PZG N/A
  • Revenue
  • CDIO $34,890.00
  • PZG N/A
  • Revenue This Year
  • CDIO $1,434.82
  • PZG N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • PZG N/A
  • P/E Ratio
  • CDIO N/A
  • PZG N/A
  • Revenue Growth
  • CDIO 104.45
  • PZG N/A
  • 52 Week Low
  • CDIO $0.19
  • PZG $0.31
  • 52 Week High
  • CDIO $1.77
  • PZG $0.69
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 68.01
  • PZG 52.58
  • Support Level
  • CDIO $0.30
  • PZG $0.36
  • Resistance Level
  • CDIO $0.43
  • PZG $0.42
  • Average True Range (ATR)
  • CDIO 0.06
  • PZG 0.03
  • MACD
  • CDIO 0.02
  • PZG 0.00
  • Stochastic Oscillator
  • CDIO 90.15
  • PZG 48.07

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About PZG Paramount Gold Nevada Corp.

Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, it is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. It enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Paramount tries to realize the value of its projects by selling its projects to producers; joint venturing its projects with other companies; or building and operating small mines on its own. Its projects include sleeper gold, grassy mountain gold, frost project; other non-material, and mineral resources.

Share on Social Networks: